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Flow-through apparatusAbstract The purpose of this work was to determine the effect of starch hydrolysates (SH) on the
physicochemical properties of suppositories. The study was conducted with suppositories with acet-
aminophen (AAP) a typical antipyretic analgesic, as model drug on lipophilic (cocoa butter) and
hydrophilic base (polyethylene glycol 1500 + 400). The suppositories with and without the addition
of SH were examined for physicochemical tests according to European Pharmacopoeia 8th edition
(Ph. Eur.): the uniformity of mass of single-dose preparation test, the softening time determination
of lipophilic suppositories test, the disintegration of suppositories test, and dissolution test with
flow-through apparatus. The results confirm the possibility of using starch hydrolysates as a cheap
and safe addition to modify physicochemical properties of suppositories.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The rectal route for drug administration is useful because it
can avoid hepatic first-pass effect, decrease gastrointestinal
side effects and avoid undesirable effects of meals on drug
absorption (de Boer et al., 1979, 1982). Drugs with systemic
effect such as, antipyretic, anti-rheumatic, muscle relaxants,
hypnotics are used in the rectal suppositories (Lou et al.,
2012; Setoguchi et al., 2013). Drugs with local effect are mainly
used: anti-inflammatories, and local anesthetics astringent nor-mally used in the treatment of hemorrhoids, and substances
with laxative activity (Carbone et al., 2013; Ramadan, 2013).
Suppositories are currently a small part of the available dosage
forms. However, the administration by the rectal route is
important for patients with peptic ulcers, children and geri-
atric’s treatment. Sustained release suppositories are preferable
to conventional suppositories because they reduce the fre-
quency of drug administration. Several approaches have been
performed to prepare the controlled release suppositories by
using various additives such as lecithin (Nishihata et al.,
1985), sucrose fatty ester (Nakajima et al., 1990), carboxyvinyl
polymer (Azechi et al., 2000; Yahagi et al., 2000) and various
hydrogel formulations (Morimoto et al., 1989; Miyazaki et al.,
1998).
Unfortunately, the amount of data on formulations con-
taining starch hydrolysates is limited. Therefore, the purpose
of this study was to demonstrate the effect of starch hydrolysis
products on physicochemical properties of suppositories.aceutical
2 P. Belniak et al.2. Materials and method
2.1. Materials
The following materials were used: potato starch (Nowamyl S.
A., Lobez, Poland), acetaminophen (AAP) (Sigma-Aldrich, St.
Louis, MO, USA), citric acid (CA), glacial acetic acid (GAA),
ethanol (760 g/L) - (ET), and phosphate buffer (pH 7.2) - (PB),
(Avantor Performance Materials S.A., Gliwice, Poland).
2.2. Methods
2.2.1. Hydrolysis of starch
Potato starch was treated with solutions of CA, GAA and water
at 95 C for 2 or 4 h to obtain starch hydrolysate SH2 or SH4
respectively. Received sediments were cleaned by ET and evapo-
rated to eliminate the solvent (Czarnecki and Belniak, 2007).
Molecular mass of obtained hydrolysates was estimated in cryo-
scope (Trident 800 CL, Poland) on the ground of freezing point
determination. Molecular mass of SH2 amounts 2.356 kDa and
1.105 kDa for SH4. Both hydrolysates are readily soluble in
water and in PB. Hydrolysates dissolved in water form solutions
of pH 3.74 and pH 3.54 while PB solutions reach pH 7.11 and
pH 7.07, respectively for the SH2 and SH4.
2.2.2. Preparation of suppositories
Rectal suppositories were prepared by fusion method at 36 C
on lipophilic base - cocoa butter and 60 C on a hydrophilic base
- PEG 1500 + PEG 400 (95:5, m/m). Each one contains 125 mg
of AAP. The molten bases were mixed with SH2, SH4 (Table 1),
and poured into polyethylene molds of capacity 1 g. After solid-
ification, formed suppositories were stored at 4 C until use.
2.2.3. Physical tests of suppositories
The uniformity of mass of single-dose preparation test was carried
out as follows: twenty suppositories were individually weighted
(Mettler AT201 FACT Switzerland) from each formula. Aver-
age mass and standard deviation (SD) were calculated.
The softening time determination of lipophilic suppositories
test was conducted using apparatus for measuring the soften-
ing time of suppositories (n= 3).Table 1 Code and constituents of suppositories.
Codes Substances (g)
AAP SH2 SH4
C0 0.125 – –
C1 0.125 0.1 –
C2 0.125 0.2 –
C3 0.125 0.3 –
C4 0.125 – 0.1
C5 0.125 – 0.2
C6 0.125 – 0.3
P0 0.125 – –
P1 0.125 0.1 –
P2 0.125 0.2 –
P3 0.125 0.3 –
P4 0.125 – 0.1
P5 0.125 – 0.2
P6 0.125 – 0.3
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water maintained at 37 C± 0.5 C using ST30 apparatus
(Erweka, Germany) (n= 3).
The resistance to rupture of suppositories test was carried
out on 10 suppositories using SBT apparatus (Erweka, Ger-
many) at room temperature (22 C± 0.5 C). Results of above
tests are shown in Table 2.
2.2.4. Assay of acetaminophen by spectrophotometry
Spectrophotometric measurements were carried out on spec-
trometer Helios Omega UV–VIS (Thermo Scientific, USA).
Absorbance of AAP in PB was taken at 242 nm and was plot-
ted against its respective concentrations to obtain standard
curve. The amount of AAP was calculated from the linear
regression equation A = 0.0625 C + 0.0188 (r = 0.9997).
2.2.5. Chemical test of suppositories
The uniformity of content of single-dose preparation test. The
content of AAP in suppositories was tested on five supposito-
ries randomly selected from each formula. The suppository was
individually placed in 1000 ml standard flask containing 100 ml
of PB and heated. The flask was shaken until complete dissolu-
tion of AAP from suppository. Then 10 ml of solution was
taken, filtrated through PVDF membrane filter (Sartorius
0.2 lm) and assayed spectrophotometrically against the blank
prepared using respective suppository without AAP. The mean
contents of drug ± SD were calculated and are given in Table 2.
The dissolution test for solid dosage forms. The dissolution
test of suppositories was carried out according to the flow-
through method. Each suppository was located in dual cham-
ber cell (Sotax, Switzerland) through which PB was pumped
(4 mL/min) at a temperature of 37 ± 0.5 C. The eluate was
filtered (Whatman GF/D 3 lm) upon leaving the cell and then
was collected in fractions with fraction collector (Buchi,
Switzerland). Samples were suitably diluted and assayed spec-
trophotometrically at 242 nm against PB. Results were
expressed as the mean of five determinations.
2.2.6. Statistical analysis
Presented data, as mean ± SD (n= 3) were analyzed by the
one-way analysis of variance ANOVA with post-hoc Dun-Cocoa butter PEG 1500 PEG 400
0.875 – –
0.775 – –
0.675 – –
0.575 – –
0.775 – –
0.675 – –
0.575 – –
– 0.831 0.044
– 0.736 0.039
– 0.641 0.034
– 0.546 0.029
– 0.736 0.039
– 0.641 0.034
– 0.546 0.029
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Table 2 Physicochemical tests.
Codes Average weight (g)
± SD n= 20
Softening time (min)
± SD n= 3
Disintegration time (min)
± SD n= 3
Resistance to rupture (kg)
± SD n= 10
Drug content (%)
± SD n= 5
C0 1.081 (0.32) 3.06 (0.86) 2.68 (1.46) 1.7 (0.15) 98 (2.06)
C1 1.127 (0.29) 4.43 (0.56) 3.97 (1.06) 2.7 (0.45) 98.2 (2)
C2 1.144 (0.41) 4.43 (0.48) 4.15 (0.57) 2.9 (0.35) 100.8 (1.9)
C3 1.190 (0.05) 5.38 (0.77) 4.25 (0.73) 2.5 (0.77) 101.8 (0.76)
C4 1.095 (0.46) 4.06 (1.29) 3.7 (0.81) 2.5 (0.82) 99.9 (2.17)
C5 1.159 (0.08) 4.28 (0.54) 4.5 (0.41) 2.0 (0.46) 100.1 (1.35)
C6 1.178 (0.11) 5.55 (0.47) 10.98 (0.67) 2.5 (0.56) 102.1 (1.7)
P0 1.324 (0.12) 15.51 (0.96) 15.75 (1.02) 1.0 (0.29) 107.9 (1.75)
P1 1.348 (0.21) 19.3 (0.68) 16.93 (0.76) 0.8 (0.64) 105.4 (1.99)
P2 1.358 (0.36) 17.5 (1.22) 25.36 (1.21) 1.0 (1.23) 107.8 (2.13)
P3 1.361 (0.25) 19.23 (0.76) 32.53 (0.95) 0.9 (0.84) 106.5 (1.63)
P4 1.348 (0.36) 17.46 (0.49) 16.0 (0.52) 0.9 (0.61) 104.5 (1.83)
P5 1.344 (0.09) 14.5 (0.88) 20.08 (0.62) 0.9 (0.39) 105.3 (1.43)
P6 1.364 (0.15) 15.23 (0.66) 25.05 (0.43) 1.0 (0.17) 103.2 (1.38)
Comparison of physicochemical properties of suppositories 3nett’s test. Differences of p< 0.05 were considered statistically
significant.
3. Results and discussion
3.1. The evaluation of physicochemical properties of
suppositories
The preparation of starch hydrolysates (SH2 and SH4) was
obtained according to our patent. Next, 14 series of rectal sup-
pository were prepared by Fusion method (Table 1). Physical
and chemical studies were carried out on all prepared series.
The obtained average results of physicochemical tests are sum-
marized in Table 2 and the results of dissolution of AAP were
presented in Figs. 1–4.
It was found that the uniformity of mass of single-dose
preparation test of all series of suppositories was within
±5%, and thus met the requirements of Ph. Eur.0
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Figure 1 The effect of SH2 on the release o
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be within acceptable values of Ph. Eur. All lipophilic supposito-
ries were deformed in 15 min, and hydrophilic suppositories were
dissolved during the 60 min. Furthermore, in the case of a lipo-
philic suppositories, it was noted that the higher the percentage
of SH addition, the longer the time of softening: suppositories
without SH – 3.06 min. Series of suppositories with 30% of
SH2 increased the time by 2.32 min and 30% of SH4 -
2.49 min compared to suppository without SH. There was no
correlation between the increasing time of deformation and an
increasing percentage of SH addition, for PEG suppositories.
Examining the disintegration time, it was found that sup-
positories without SH were disintegrated quickly (cocoa oil –
2.68 min, PEG – 15.75 min), while suppositories with SH were
disintegrated proportionally longer, respectively by 1.57 min
for 30% of SH2, 8.3 min for 30% of SH4 - cocoa oil, and
16.78 min for 30% of SH2, 9.3 min for 30% of SH4 - PEG
based. All series met the requirements of Ph. Eur.200 250 300 350
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Figure 4 The effect of SH4 on the release of AAP from PEG suppositories.
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Figure 3 The effect of SH2 on the release of AAP from PEG suppositories.
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Figure 2 The effect of SH4 on the release of AAP from cocoa butter suppositories.
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cocoa oil suppositories without SH, characterized the lowest
hardness (1.7 kg). While suppositories containing 20% of
SH2 were the hardest (2.9 kg), PEG suppositories with 10%
of SH2 had the lowest hardness (0.8 kg), and the similar hard-
ness (0.9–1.0 kg) was obtained at the same time for supposito-
ries: without hydrolysates, 20% and 30% of SH2 and SH4. No
correlation was found between the percentage of starch hydro-
lysates and resistance to crushing.
The research of the uniformity of content of single-dose in
each series of suppositories, confirmed, that all series met the
requirements of Ph. Eur. in the range of ±10%.
3.2. The dissolution of AAP from suppositories in vitro
The study of dissolution of AAP from lipophilic suppositories
was performed during 6 h, and hydrophilic suppositories
required much shorter time - 40 min according to the literature
(Janicki et al., 2001; Saleem et al., 2008).
The lipophilic suppositories without SH released only
15.88 mg AAP in 350 min, which was approximately 13% of
the total drug content. The addition of both SH2 and SH4 sig-
nificant increased the amount of released AAP – series with
SH2 - C2 (p< 0.01) and C3 (p< 0.001) compared to C0
(the one-way ANOVA: F(3,35) = 18.77). Series with SH4 –
C5, C6 (p< 0.01) (the one-way ANOVA: F(3,52) = 21.45).
It is noted that the addition of 10% of both SH2 and SH4
had no significant effect on the amount of release AAP
(p> 0.05).
The release of AAP from the PEG suppositories was car-
ried out in 40 min. It was observed that this time was sufficient
to release the whole amount of the drug from the suppository.
Suppositories without SH released 133.38 mg AAP, and
increasing the amount of SH2 resulted in a prolongation of
the release time and consequent approximately 20% decrease
in the amount of the drug released for a series of 30% of
SH2, whose release profile was similar to the zero-order reac-
tion. In the case of suppositories with SH4 addition of 10%
or 20% did not cause significant differences between supposi-
tories without SH (p> 0.05). Only addition of 30% of SH4
showed a different release profile and a small decrease in the
quantity of the released substance (approx. 5%).
The highest release rate of the drug from the PEG suppos-
itories was observed during the first 20 min of the study.
4. Conclusion
The addition of starch hydrolysates increased time of softening
and disintegration of suppositories. The suppositories contain-
ing 30% SH have the longest softening and disintegration
time. No correlation was found between the percentage of
starch hydrolysates and resistance to crushing. Higher percent-
age of the starch hydrolysate in PEG suppositories caused
longer active substance release but for cocoa oil suppository,
it caused reduction in dissolution time. This can be explainedPlease cite this article in press as: Belniak, P. et al., Comparison of physicochemical p
Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.09.004that the readily soluble starch hydrolysates facilitate the pene-
tration of water into lipophilic suppository, and therefore AAP
has better conditions for release.
The use of starch hydrolysates as a suppository modifying
excipient of physicochemical properties, seems promising.
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